Functional consequences of the binding of MHC class II-derived peptides to MHC class II

被引:7
作者
FeiliHariri, M
Kao, H
Mietzner, TA
Morel, PA
机构
[1] UNIV PITTSBURGH,INST CANC,PITTSBURGH,PA 15213
[2] UNIV PITTSBURGH,DEPT MED,PITTSBURGH,PA 15213
[3] UNIV PITTSBURGH,DEPT MOL GENET & BIOCHEM,PITTSBURGH,PA 15213
关键词
MHC class II; non-obese diabetic mouse; peptide antagonists;
D O I
10.1093/intimm/8.12.1857
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Three MHC class II-derived synthetic peptides (I-A(beta)(g7)1-16, I-A(beta)(g7)52-77 and I-A(alpha)(g7)63-82YC) were analyzed for their ability to bind to syngeneic and allogeneic MHC class II molecules using a whole cell, competitive peptide binding assay, These studies demonstrated that the A(beta)(g7)1-16 peptide was able to specifically bind to syngeneic as well as to four allogeneic MHC class II molecules. The A(alpha)(g7)63-82YC peptide bound to self MHC class II molecules with a lower relative affinity and was able to bind to three out of the four allogeneic cells tested, The binding of the three I-A(g7)-derived peptides to the self MHC class II was functionally significant, The A(beta)(g7)1-16 and A(beta)(g7)52-77 peptides inhibited the proliferation of a heat shock protein 60 peptide-specific T(h)1 clone by MHC blockade, Interestingly, the A(alpha)(g7)63-82YC peptide appeared to interact directly with T cells as pretreatment of the T(h)1 clone with this peptide resulted in inhibition of antigen-induced proliferation. This phenomenon was analyzed in more detail and it was found that this peptide could behave as a partial agonist. Incubation of T cells with the A(alpha)(g7)63-82YC peptide resulted in up-regulation of IL-2R alpha chain expression and induction of IFN-gamma secretion. In addition T cells pretreated with this peptide were rendered hyporesponsive to further antigenic stimulation. Thus, a peptide derived from MHC class II may be used in an immunoregulatory capacity.
引用
收藏
页码:1857 / 1865
页数:9
相关论文
共 31 条
[1]  
BANERJEE S, 1991, IMMUNOGENETICS AUTOI, P119
[2]   DONOR MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) PEPTIDES ARE PRESENTED BY RECIPIENT MHC MOLECULES DURING GRAFT-REJECTION [J].
BENICHOU, G ;
TAKIZAWA, PA ;
OLSON, CA ;
MCMILLAN, M ;
SERCARZ, EE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) :305-308
[3]   IMMUNOGENICITY AND TOLEROGENICITY OF SELF-MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDES [J].
BENICHOU, G ;
TAKIZAWA, PA ;
HO, PT ;
KILLION, CC ;
OLSON, CA ;
MCMILLAN, M ;
SERCARZ, EE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (05) :1341-1346
[4]   PREVENTION OF DIABETES IN NONOBESE DIABETIC MICE BY ANTI-I-A MONOCLONAL-ANTIBODIES - TRANSFER OF PROTECTION BY SPLENIC T-CELLS [J].
BOITARD, C ;
BENDELAC, A ;
RICHARD, MF ;
CARNAUD, C ;
BACH, JF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (24) :9719-9723
[5]   9-FLUORENYLMETHOXYCARBONYL AMINO-PROTECTING GROUP [J].
CARPINO, LA ;
HAN, GY .
JOURNAL OF ORGANIC CHEMISTRY, 1972, 37 (22) :3404-&
[6]  
CarrascoMarin E, 1996, J IMMUNOL, V156, P450
[7]  
CEREDIG R, 1985, NATURE, V314, P89
[8]   SPECIFICITY AND PROMISCUITY AMONG NATURALLY PROCESSED PEPTIDES BOUND TO HLA-DR ALLELES [J].
CHICZ, RM ;
URBAN, RG ;
GORGA, JC ;
VIGNALI, DAA ;
LANE, WS ;
STROMINGER, JL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (01) :27-47
[9]  
CLAYBERGER C, 1994, J IMMUNOL, V153, P946
[10]   HLA-A2 PEPTIDES CAN REGULATE CYTOLYSIS BY HUMAN ALLOGENEIC LYMPHOCYTES-T [J].
CLAYBERGER, C ;
PARHAM, P ;
ROTHBARD, J ;
LUDWIG, DS ;
SCHOOLNIK, GK ;
KRENSKY, AM .
NATURE, 1987, 330 (6150) :763-765